Nicholas Sellke1, Alex Kuczmarski1, Isabella Lawandy1, Victoria L Cole1, Afshin Ehsan1, Arun K Singh1, Yuhong Liu1, Frank W Sellke1, Jun Feng2. 1. Division of Cardiothoracic Surgery, Department of Surgery, Cardiovascular Research Center, Rhode Island Hospital, Alpert Medical School of Brown University, Rhode Island Hospital, Providence, RI. 2. Division of Cardiothoracic Surgery, Department of Surgery, Cardiovascular Research Center, Rhode Island Hospital, Alpert Medical School of Brown University, Rhode Island Hospital, Providence, RI. Electronic address: jfeng@lifespan.org.
Abstract
OBJECTIVE: Cardioplegic arrest (CP) and cardiopulmonary bypass (CPB) are associated with vasomotor dysfunction of coronary arterioles in patients with diabetes (DM) undergoing cardiac surgery. We hypothesized that DM may up-regulate vasopressin receptor expression and alter the contractile response of coronary arterioles to vasopressin in the setting of CP/CPB. METHODS: Right atrial tissue samples of patients with DM and without (ND) (n = 8 in each group) undergoing cardiac surgery were harvested before and after CP/CPB. The isolated coronary arterioles (80-150 μm) dissected from the harvested right atrial tissue samples were cannulated and pressurized (40 mm Hg) in a no-flow state. The changes in diameter were measured with video microscopy. The protein expression/localization of vasopressin 1A receptors (V1A) and vasopressin 1B receptors (V1B) in the atrial tissue were measured by immune-blotting and immunohistochemistry. RESULTS: The pre-CP/CPB contractile responses of the coronary arterioles to vasopressin were significantly increased post-CP/CPB in both the ND and DM groups. This effect was more pronounced in the vessels from patients in the DM group than that of vessels from patients in the ND group (P < .05). Vasopressin-induced contractile response of the coronary arterioles was inhibited in the presence of the specific V1A antagonist SR 49059 (10-7 M) in both ND and DM vessels (P < .05). The post-CP/CPB protein levels of V1A were significantly increased compared with pre-CP/CPB values in both the ND and DM groups (P < .05), whereas this increase was greater in DM than that of ND (P < .05). Immunohistochemistry staining further indicates that V1B were mainly expressed in the myocardium but not in vascular smooth muscle. CONCLUSIONS: CP/CPB and DM are both associated with up-regulation in V1 receptor expression/localization in human myocardium. Vasopressin may induce coronary arteriolar constriction via V1A. This alteration may lead to increased coronary arteriolar spasm in patients with DM undergoing CP/CPB and cardiac surgery.
OBJECTIVE:Cardioplegic arrest (CP) and cardiopulmonary bypass (CPB) are associated with vasomotor dysfunction of coronary arterioles in patients with diabetes (DM) undergoing cardiac surgery. We hypothesized that DM may up-regulate vasopressin receptor expression and alter the contractile response of coronary arterioles to vasopressin in the setting of CP/CPB. METHODS: Right atrial tissue samples of patients with DM and without (ND) (n = 8 in each group) undergoing cardiac surgery were harvested before and after CP/CPB. The isolated coronary arterioles (80-150 μm) dissected from the harvested right atrial tissue samples were cannulated and pressurized (40 mm Hg) in a no-flow state. The changes in diameter were measured with video microscopy. The protein expression/localization of vasopressin 1A receptors (V1A) and vasopressin 1B receptors (V1B) in the atrial tissue were measured by immune-blotting and immunohistochemistry. RESULTS: The pre-CP/CPB contractile responses of the coronary arterioles to vasopressin were significantly increased post-CP/CPB in both the ND and DM groups. This effect was more pronounced in the vessels from patients in the DM group than that of vessels from patients in the ND group (P < .05). Vasopressin-induced contractile response of the coronary arterioles was inhibited in the presence of the specific V1A antagonist SR 49059 (10-7 M) in both ND and DM vessels (P < .05). The post-CP/CPB protein levels of V1A were significantly increased compared with pre-CP/CPB values in both the ND and DM groups (P < .05), whereas this increase was greater in DM than that of ND (P < .05). Immunohistochemistry staining further indicates that V1B were mainly expressed in the myocardium but not in vascular smooth muscle. CONCLUSIONS:CP/CPB and DM are both associated with up-regulation in V1 receptor expression/localization in human myocardium. Vasopressin may induce coronary arteriolar constriction via V1A. This alteration may lead to increased coronary arteriolar spasm in patients with DM undergoing CP/CPB and cardiac surgery.
Authors: Michael P Robich; Eugenio G Araujo; Jun Feng; Robert M Osipov; Richard T Clements; Cesario Bianchi; Frank W Sellke Journal: J Thorac Cardiovasc Surg Date: 2009-07-25 Impact factor: 5.209
Authors: V H Thourani; W S Weintraub; B Stein; S S Gebhart; J M Craver; E L Jones; R A Guyton Journal: Ann Thorac Surg Date: 1999-04 Impact factor: 4.330
Authors: Susana Novella; Ana Cristina Martínez; Rosa María Pagán; Medardo Hernández; Albino García-Sacristán; Angel González-Pinto; José María González-Santos; Sara Benedito Journal: Eur J Cardiothorac Surg Date: 2007-05-15 Impact factor: 4.191
Authors: Subodh Verma; Andrew Maitland; Richard D Weisel; Paul W M Fedak; Shu-Hong Li; Donald A G Mickle; Ren-Ke Li; Lawrence Ko; Vivek Rao Journal: J Thorac Cardiovasc Surg Date: 2002-06 Impact factor: 5.209
Authors: Benjamin Mirman; Ian Ikeda; Zhiqi Zhang; Yuhong Liu; Lucy Yu; Afshin Ehsan; Jun Feng; Frank Sellke Journal: Surgery Date: 2020-05-31 Impact factor: 3.982
Authors: Laura A Scrimgeour; Ian Ikeda; Nicholas C Sellke; Guangbin Shi; Jun Feng; Sevdenur Cizginer; Afshin Ehsan; Neel R Sodha; Frank W Sellke Journal: J Card Surg Date: 2021-10-28 Impact factor: 1.620